Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank14
3Y CAGR-32.9%
5Y CAGR-19.1%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-32.9%/yr
vs +1.2%/yr prior
5Y CAGR
-19.1%/yr
Recent deceleration
Acceleration
-34.1pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$108.42M-34.1%
2024$164.42M-31.6%
2023$240.44M-32.9%
2022$358.17M+17.3%
2021$305.31M-2.5%
2020$313.05M+6.1%
2019$294.96M-13.5%
2018$341.19M+89.2%
2017$180.29M-0.1%
2016$180.38M-